Skip to content

Study on the diagnosis and prognosis assessment value of detection the peripheral blood circulating tumor cell in patients with malignant biliary stenosis

Study on the diagnosis and prognosis assessment value of detection the peripheral blood circulating tumor cell in patients with malignant biliary stenosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17011774
Enrollment
Unknown
Registered
2017-06-28
Start date
2017-07-06
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant biliary stenosis

Interventions

Gold Standard:Gold standard: bile duct cell brush examination, ERCP and bile duct ultrasonography
tumor&#32
in&#32
peripheral&#32
blood

Sponsors

Zhongnan Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. aged 18 - 75 years male and female; 2. obstructive jaundice with progressive exacerbation; 3. the malignant lesions were confirmed by ERCP + idus + cell brush biopsy or tissue biopsy; 4. malignant bile duct obstruction diagnosed for the first time (including the diagnosis of the first treatment of the outer court for the first time); 5. signing of the letter of informed consent.

Exclusion criteria

Exclusion criteria: 1. patients who have been diagnosed with malignant tumors of other systems or organs; 2. patients with blood system diseases and severe body failure; 3. patients with immune deficiency and organ transplantation; 4. the researchers think it is inappropriate to participate in other circumstances of this study. In addition, in order to ensure the reliability of CTCs detection results, 20 non - tumor patients in our department were collected as negative control group during the same period. Another 20 patients with malignant tumor were collected as positive control group.

Design outcomes

Primary

MeasureTime frame
circulating tumor cell;

Countries

China

Contacts

Public ContactWang Hongling

Zhongnan Hospital of Wuhan University

zhnwhl@whu.edu.cn+86 13986072929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026